Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josko Bozic

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
World Journal of Clinical Cases|April 25, 2024
Discontinuation of therapy in inflammatory bowel disease: Current viewsAntonio Meštrović, Marko Kumric, Josko Bozic
Medicina (Kaunas, Lithuania)|August 27, 2021
Impact of Different <i>Helicobacter pylori</i> Eradication Therapies on Gastrointestinal SymptomsAntonio Mestrovic, Josko Bozic, Katarina Vukojevic, et al.
International Journal of Molecular Sciences|June 26, 2026
Diet, Gut Microbiome, and Microbial Metabolites in Inflammatory Bowel Disease: From Functional Dysbiosis to Precision NutritionJosko Bozic, Roko Santic, Piero Marin Zivkovic, et al.
Heart, Lung & Circulation|May 25, 2019
Predicting the 1-Year All-Cause Mortality After Hospitalisation for an Acute Heart Failure Event: A Real-World Derivation Cohort for the Development of the S<sub>2</sub>PLiT-UG ScoreJosip A Borovac, Duska Glavas, Josko Bozic, et al.
World Journal of Cardiology|September 4, 2020
Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkersJosip Anđelo Borovac, Domenico D'Amario, Josko Bozic, et al.
Heart and Vessels|August 31, 2018
The midrange left ventricular ejection fraction (LVEF) is associated with higher all-cause mortality during the 1-year follow-up compared to preserved LVEF among real-world patients with acute heart failure: a single-center propensity score-matched analysisJosip Anđelo Borovac, Katarina Novak, Josko Bozic, et al.
Journal of Personalized Medicine|July 27, 2022
Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension (HYPER-H21-4): Study Protocol for a Randomized, Placebo-Controlled, and Crossover StudyMarko Kumric, Josko Bozic, Goran Dujic, et al.
World Journal of Diabetes|June 25, 2021
Role of novel biomarkers in diabetic cardiomyopathyMarko Kumric, Tina Ticinovic Kurir, Josip A Borovac, et al.
Cannabis and Cannabinoid Research|April 24, 2023
Chronic Effects of Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure in Patients with Hypertension (HYPER-H21-4): A Randomized, Placebo-Controlled, and Crossover StudyGoran Dujic, Marko Kumric, Josip Vrdoljak, et al.
Kidney & Blood Pressure Research|June 6, 2015
The missing link - likely pathogenetic role of GM3 and other gangliosides in the development of diabetic nephropathyIgor Vukovic, Josko Bozic, Anita Markotic, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
World Journal of Clinical Cases|April 25, 2024
Discontinuation of therapy in inflammatory bowel disease: Current viewsAntonio Meštrović, Marko Kumric, Josko Bozic
Medicina (Kaunas, Lithuania)|August 27, 2021
Impact of Different <i>Helicobacter pylori</i> Eradication Therapies on Gastrointestinal SymptomsAntonio Mestrovic, Josko Bozic, Katarina Vukojevic, et al.
International Journal of Molecular Sciences|June 26, 2026
Diet, Gut Microbiome, and Microbial Metabolites in Inflammatory Bowel Disease: From Functional Dysbiosis to Precision NutritionJosko Bozic, Roko Santic, Piero Marin Zivkovic, et al.
Heart, Lung & Circulation|May 25, 2019
Predicting the 1-Year All-Cause Mortality After Hospitalisation for an Acute Heart Failure Event: A Real-World Derivation Cohort for the Development of the S<sub>2</sub>PLiT-UG ScoreJosip A Borovac, Duska Glavas, Josko Bozic, et al.
World Journal of Cardiology|September 4, 2020
Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkersJosip Anđelo Borovac, Domenico D'Amario, Josko Bozic, et al.
Heart and Vessels|August 31, 2018
The midrange left ventricular ejection fraction (LVEF) is associated with higher all-cause mortality during the 1-year follow-up compared to preserved LVEF among real-world patients with acute heart failure: a single-center propensity score-matched analysisJosip Anđelo Borovac, Katarina Novak, Josko Bozic, et al.
Journal of Personalized Medicine|July 27, 2022
Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension (HYPER-H21-4): Study Protocol for a Randomized, Placebo-Controlled, and Crossover StudyMarko Kumric, Josko Bozic, Goran Dujic, et al.
World Journal of Diabetes|June 25, 2021
Role of novel biomarkers in diabetic cardiomyopathyMarko Kumric, Tina Ticinovic Kurir, Josip A Borovac, et al.
Cannabis and Cannabinoid Research|April 24, 2023
Chronic Effects of Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure in Patients with Hypertension (HYPER-H21-4): A Randomized, Placebo-Controlled, and Crossover StudyGoran Dujic, Marko Kumric, Josip Vrdoljak, et al.
Kidney & Blood Pressure Research|June 6, 2015
The missing link - likely pathogenetic role of GM3 and other gangliosides in the development of diabetic nephropathyIgor Vukovic, Josko Bozic, Anita Markotic, et al.
Pageof 15